The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-009-0484-0PMID 19649706PMCID PMC3108061
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk

  2008influential reference
• Clinicopathological significance of circadian rhythm‐related gene expression levels in patients with epithelial ovarian cancer

  2008influential reference
• Organization of cell and tissue circadian pacemakers: a comparison among species.

  2008cited by this paper
• The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response

  2008cited by this paper
• Disturbance of circadian gene expression in hepatocellular carcinoma

  2008cited by this paper
• Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.

  2007cited by this paper
• A sense of time: how molecular clocks organize metabolism.

  2007cited by this paper
• Variants in circadian genes and prostate cancer risk: a population-based study in China

  2007cited by this paper
• Tumor Suppression and Circadian Function

  2007influential reference
• Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphoma

  2007cited by this paper
• Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice

  2007cited by this paper
• Circadian gene mPer2 overexpression induces cancer cell apoptosis

  2006cited by this paper
• Spectroscopic and DNA‐binding characterization of the isolated heme‐bound basic helix–loop–helix‐PAS‐A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms

  2006cited by this paper
• Tumor Suppression by the Mammalian Period Genes

  2006cited by this paper
• Molecular components of the mammalian circadian clock.

  2006cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2006cited by this paper
• Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients

  2006cited by this paper
• Genetic Polymorphisms of SULT1A1 and SULT1E1 and the Risk and Survival of Breast Cancer

  2005cited by this paper
• Clock genes of mammalian cells: Practical implications in tissue culture

  2005cited by this paper
• Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.

  2005cited by this paper
• Signal transduction by heme-containing PAS-domain proteins.

  2004cited by this paper
• The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.

  2002cited by this paper
• NPAS2: An Analog of Clock Operative in the Mammalian Forebrain

  2001cited by this paper
• Mop3 is an essential component of the master circadian pacemaker in mammals.

  2000cited by this paper
• TNM classification of malignant tumors, fifth edition (1997)

  1997cited by this paper
• Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system.

  1997influential reference
• Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior.

  1994cited by this paper

• Circadian Gene NPAS2 Relieves Hypertrophic Scar Formation via CDC25A‐Mediated Fibroblasts Activity

  2025cites this paper
• Unravelling the link between circadian clock genes and brain tumors: From pathological disruptions to potential therapeutic interventions

  2025cites this paper
• Transcriptome profiling revealed multiple circadian rhythm-related genes associated with common gynecological cancers

  2025cites this paper
• The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer

  2025cites this paper
• Integrated analysis of -omic landscapes in breast cancer subtypes

  2024cites this paper
• Misalignment of Circadian Rhythms in Diet-Induced Obesity.

  2024cites this paper
• Digital Medicine

  2023cites this paper
• Role of Melatonin in Cancer: Effect on Clock Genes

  2023cites this paper
• A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer

  2023influential citation
• Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1.

  2023cites this paper
• Role of the Circadian Gas-Responsive Hemeprotein NPAS2 in Physiology and Pathology

  2023cites this paper
• Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities.

  2022cites this paper
• Circadian rhythm in prostate cancer: time to take notice of the clock

  2022cites this paper
• Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers

  2022cites this paper
• A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

  2022cites this paper
• A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression.

  2022cites this paper
• Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma

  2022cites this paper
• CMAR_A_343097 9329..9343

  2021cites this paper
• Molecular Evolution of clock Genes in Vertebrates

  2021cites this paper
• The Associations Between Circadian Genetic Factors And Cancer Survival

  2021cites this paper
• The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma

  2021cites this paper
• Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility

  2021cites this paper
• Roles of NPAS2 in circadian rhythm and disease.

  2021cites this paper
• Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis

  2020cites this paper
• Cross-species physiological interactions of endocrine disrupting chemicals with the circadian clock.

  2020cites this paper
• Light Pollution and Cancer

  2020cites this paper
• Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs

  2020cites this paper
• Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression

  2019cites this paper
• Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma

  2019influential citation
• Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility

  2019cites this paper
• Circadian genes and risk of prostate cancer: Findings from the EPICAP study

  2019cites this paper
• Altered circadian genes expression in breast cancer tissue according to the clinical characteristics

  2018cites this paper
• Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis

  2018cites this paper
• Biomarkers in Precision Medicine: The Era of Omics

  2018cites this paper
• MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells

  2017cites this paper
• NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A

  2017cites this paper
• Clock Genes and Cancer

  2017cites this paper
• Biomarkers From Systems Biology and “Omics” Studies

  2017cites this paper
• Novel roles of the circadian clock protein neuronal PAS domain protein 2 (NPAS2) in the response to oxidative and heat stress

  2017cites this paper
• Circadian clock and oral cancer

  2017cites this paper
• Circadian gene variants and breast cancer.

  2017cites this paper
• Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis

  2017cites this paper
• Circadian Genes in Breast Cancer.

  2016cites this paper
• Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

  2015cites this paper
• Current evidence on the relationship between two common polymorphisms in NPAS2 gene and cancer risk.

  2015cites this paper
• Cellular Rhythms and Networks

  2015cites this paper
• Circadian rhythms and new options for novel anticancer therapies

  2015cites this paper
• Circadian Biomarkers and Chronotherapy: Implications for Personalized and Systems Medicine

  2015cites this paper
• Genetic association study of circadian genes with seasonal pattern in bipolar disorders

  2015cites this paper
• GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer

  2015cites this paper
• Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2.

  2015cites this paper
• Circadian gene variants in cancer

  2014cites this paper
• Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients

  2014cites this paper
• Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-β-estradiol levels.

  2014cites this paper
• Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.

  2014cites this paper
• Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.

  2014cites this paper
• Lack of Association of NPAS2 Polymorphism with Chronic Lymphocytic Leukemia

  2014cites this paper
• Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.

  2013cites this paper
• Analyse de données d’expression transcriptomiques rythmées par des gènes-horloge : approche méthodologique et optimisation

  2013cites this paper
• Circadian pathway genes in relation to glioma risk and outcome

  2013cites this paper
• Diurnal cortisol rhythm as a predictor of lung cancer survival.

  2013cites this paper
• [Analysis of gene expression data regulated by clock-genes: methodological approach and optimization].

  2013cites this paper
• Haem-based sensors: a still growing old superfamily.

  2013cites this paper
• The circadian clock circuitry and the AHR signaling pathway in physiology and pathology.

  2013cites this paper
• Connecting cellular metabolism to circadian clocks.

  2013cites this paper
• Der Einfluss des Arylhydrocarbon-Rezeptors auf den circadianen Rhythmus

  2012cites this paper
• Circadian clock disruptions and the risk of cancer

  2012cites this paper
• Circadian genes and breast cancer susceptibility in rotating shift workers

  2012cites this paper
• Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer

  2012cites this paper
• A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma

  2012cites this paper
• Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes

  2011cites this paper
• Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer.

  2011cites this paper
• A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk

  2011cites this paper
• Circadian rhythms and cancer

  2010cites this paper
• Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways.

  2010cites this paper
• Chronotherapy and the molecular clock: Clinical implications in oncology.

  2010cites this paper
• Healthy clocks, healthy body, healthy mind

  2010cites this paper
• Disrupting the circadian clock: Gene-specific effects on aging, Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes cancer, and other phenotypes

  year unknowncites this paper
• RESEARCH ARTICLE Lack of Association of the NPAS2 Gene Ala394Thr Polymorphism (rs2305160:G>A) with Risk of Chronic Lymphocytic Leukemia

  year unknowncites this paper